Erianin
Cat.No:IE0580 Solarbio
CAS:95041-90-0
Molecular Formula:C18H22O5
Molecular Weight:318.36
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Others >
ErianinCAS:95041-90-0
Molecular Formula:C18H22O5
Molecular Weight:318.36
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 95041-90-0 |
Name | Erianin |
Molecular Formula | C18H22O5 |
Molecular Weight | 318.36 |
Solubility | Soluble in DMSO |
Purity | HPLC≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 1312995-182-4 |
MDL | MFCD06795132 |
SMILES | OC1=CC(CCC2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC |
Target Point | Others |
Passage | Others |
Background | It inhibits indoleamine-2,3-dioxygenase (IDO)-induced tumor angiogenesis. |
Biological Activity | Erianin能够抑制IDO诱导的肿瘤血管生成[1-2]。 |
Data Literature Source | [1]. Su C,et al. Erianin inhibits indoleamine 2,3-dioxygenase -induced tumor angiogenesis. Biomed Pharmacother. 2017 Apr;88:521-528. [2]. Li M,et al. Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway. Oncol Lett. 2018 Oct;16(4):5006-5012. |
Unit | Bottle |
Specification | 5mg 10mM*1mL in DMSO 10mg 20mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.